Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1989
Cilastatin-insulin interaction in the ratG C Tompkins, L J Brunner, D R LukeStroke|November 3, 2001
Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic strokeD C Morris, L Zhang, Z G Zhang, et al.Antimicrobial Agents and Chemotherapy|November 1, 1996
Safety, toleration, and pharmacokinetics of intravenous azithromycinD R Luke, G Foulds, S F Cohen, et al.Renal Failure|January 1, 1993
Influence of pentoxifylline on renal function in HIV-seropositive patientsD R Luke, T P Sarnoski, N Bell, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1991
Tissue distribution and in vivo immunosuppressive activity of liposomal cyclosporineK Vadiei, G Lopez-Berestein, R Perez-Soler, et al.Antimicrobial Agents and Chemotherapy|August 1, 1995
Pharmacokinetics of azithromycin in pediatric patients with acute otitis mediaM C Nahata, K I Koranyi, D R Luke, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1992
Failure of predicted creatinine clearance equations in HIV-seropositive patientsB L Smith, T P Sarnoski, S Dennis, et al.Renal Failure|January 1, 1989
Prevention of cyclosporine-induced nephrotoxicity with pentoxifyllineL J Brunner, K Vadiei, L V Iyer, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1991
Reassessment of dapsone as a marker of acetylator phenotypesE B Wiggan, S Dennis, S B Reele, et al.Clinical Chemistry|February 1, 1990
Increased sensitivity in a radioimmunoassay for measuring cyclosporine in lipoprotein fractionsL J Brunner, J C Yau, J Lautersztain, et al.Pageof 7